SEARCH BY
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 46 |
| Sector: Life Science M&A | 14 of 41 |
| Type: Add-on Acquisition M&A Deals | 14 of 33 |
| State: North Carolina M&A | 2 of 3 |
| Country: United States M&A | 14 of 33 |
| Year: 2011 M&A | 3 of 5 |
| Size (of disclosed) | 23 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-04-04 |
Capsugel Belgium NV
Colmar, France Capsugel Belgium NV is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel offers a comprehensive array of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative R&D equipment and liquid formulations as part of its Licaps Drug Delivery System. |
Sell | $2.4B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-09-13 |
AM-Pharma
Utrecht, Netherlands AM-Pharma is a biopharmaceutical company developing a biotherapeutic for the treatment of Acute Kidney Injury. The company initiated a 290 patient phase 2 study of recombinant human Alkaline Phosphatase in Acute Kidney Injury. AM-Pharma was founded in 2000 and is based in Utrecht, Netherlands. |
Buy | - |
